{
  "questions": [
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39555889"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39555889",
          "text": "RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.. The binding of peptides to class-I Major Histocompability Complex (MHC) receptors and their subsequent recognition downstream by T-cell receptors are crucial processes for most mult...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.26385921239852905,
          "rerank_position": 1
        }
      ],
      "id": "67d74cde18b1e36f2e00003c",
      "type": "summary",
      "body": "Describe RankMHC"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/35977725",
        "http://www.ncbi.nlm.nih.gov/pubmed/31365134",
        "http://www.ncbi.nlm.nih.gov/pubmed/29154906",
        "http://www.ncbi.nlm.nih.gov/pubmed/31538196",
        "http://www.ncbi.nlm.nih.gov/pubmed/37069528",
        "http://www.ncbi.nlm.nih.gov/pubmed/33955776",
        "http://www.ncbi.nlm.nih.gov/pubmed/10322219",
        "http://www.ncbi.nlm.nih.gov/pubmed/9342339",
        "http://www.ncbi.nlm.nih.gov/pubmed/32716929",
        "http://www.ncbi.nlm.nih.gov/pubmed/24354965"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35977725",
          "text": "Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.. AIMS: Anaplastic ganglioglioma is a rare tumour, and diagnosis has been based on histological criteria. The 5th edition of the World Health Organization Classification...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3859785795211792,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31365134",
          "text": "Revisiting the classification of adhesion GPCRs.. G protein-coupled receptors (GPCRs) are encoded by over 800 genes in the human genome. Motivated by different scientific rationales, the two classification systems that are mainly in use, the ABC a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2993392050266266,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29154906",
          "text": "Increase in taxonomic assignment efficiency of viral reads in metagenomic studies.. Metagenomics studies have revolutionized the field of biology by revealing the presence of many previously unisolated and uncultured micro-organisms. However, one ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.26851969957351685,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31538196",
          "text": "Hunting the Snark: the flawed search for mythical Jurassic angiosperms.. Several recent palaeobotanical studies claim to have found and described pre-Cretaceous angiosperm macrofossils. With rare exceptions, these papers fail to define a flower, d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.24550968408584595,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37069528",
          "text": "Multimodal ultrasound features of breast cancers: correlation with molecular subtypes.. OBJECTIVES: To investigate whether multimodal intratumour and peritumour ultrasound features correlate with specific breast cancer molecular subtypes. METHODS:...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.24300605058670044,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33955776",
          "text": "Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.. OBJECTIVE. The purpose of this study was to compare breast cancer characteristics and treatment regimens among women undergoing annual versus...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.229609414935112,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10322219",
          "text": "Predicting structures for genome proteins.. Assigning three-dimensional protein folds to genome sequences is essential to understanding protein function. Although experimental three-dimensional structures are currently available for only a very sm...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22159326076507568,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9342339",
          "text": "Assigning folds to the proteins encoded by the genome of Mycoplasma genitalium.. A crucial step in exploiting the information inherent in genome sequences is to assign to each protein sequence its three-dimensional fold and biological function. He...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22122493386268616,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32716929",
          "text": "Entrofy your cohort: A transparent method for diverse cohort selection.. Selecting a cohort from a set of candidates is a common task within and beyond academia. Admitting students, awarding grants, and choosing speakers for a conference are situa...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.1958865225315094,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24354965",
          "text": "Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.. BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait, affects ~1 in 5,000, and causes m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.19100898504257202,
          "rerank_position": 10
        }
      ],
      "id": "65f7741fc4010b4d78000027",
      "type": "factoid",
      "body": "What proportion of colorectal cancer cases are not assignable to any of the consensus molecular subtype (CMS) groups?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
        "http://www.ncbi.nlm.nih.gov/pubmed/10730545",
        "http://www.ncbi.nlm.nih.gov/pubmed/12688198",
        "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
        "http://www.ncbi.nlm.nih.gov/pubmed/16526979",
        "http://www.ncbi.nlm.nih.gov/pubmed/15095746",
        "http://www.ncbi.nlm.nih.gov/pubmed/30385603",
        "http://www.ncbi.nlm.nih.gov/pubmed/18673225",
        "http://www.ncbi.nlm.nih.gov/pubmed/16042713",
        "http://www.ncbi.nlm.nih.gov/pubmed/18998474"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
          "text": "Pharmacology of phosphodiesterase-5 inhibitors.. The clinical properties (efficacy and safety profile) of a medicine are related not only to its mode of action, but also to its selectivity for its target (usually a receptor or enzyme) and are also...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.515960693359375,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10730545",
          "text": "Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?. Research conducted over the last 20 years has established that inflammation of the airways is central to the airway dysfunction that charac...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5107210278511047,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12688198",
          "text": "[PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.5072141289710999,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
          "text": "Design of second generation phosphodiesterase 5 inhibitors.. The clinical significance of phosphodiesterase 5 (PDE5) inhibition is increasingly understood following the pioneering work with sildenafil, and the continuing development programmes for...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4986915588378906,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16526979",
          "text": "PDE5 inhibitors: are there differences?. The introduction of oral agents for the treatment of erectile dysfunction (ED) has revolutionized the treatment of men with erection problems of all severities and etiologies. Sildenafil, available on the w...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.48665598034858704,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15095746",
          "text": "Carrying short-acting nitrates is not a contra-indication to the use of PDE5 inhibitors.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "rerank_score": 0.48644009232521057,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30385603",
          "text": "An inhaled \"bifunctional\" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "rerank_score": 0.47948339581489563,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18673225",
          "text": "Structure -activity relationships of PDE5 inhibitors.. cGMP has a short-term effect on smooth muscle tone and a longer-term effect on responses to chronic drug treatment or proliferative signals. cGMP-Phosphodiesterase type 5 (PDE5) hydrolizes cGM...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4770561158657074,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16042713",
          "text": "Phosphodiesterase type 5 inhibitors for erectile dysfunction.. The cyclic nucleotide signalling pathway mediates the smooth-muscle relaxing effects of nitric oxide necessary for normal erectile function. Down-regulation of this pathway is central ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46690335869789124,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18998474",
          "text": "[Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours].. Phosphodiesterase type 5 (PDE5) inhibitors are first-line oral medication for erectile dysfunction (ED). Compared with the other two PDE inhibitors (sildenafil and vardenafi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4632757008075714,
          "rerank_position": 10
        }
      ],
      "id": "67cc973e81b1027333000011",
      "type": "list",
      "body": "Please list the short half life Phosphodiesterase 5 inhibitors."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
        "http://www.ncbi.nlm.nih.gov/pubmed/15335408",
        "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
        "http://www.ncbi.nlm.nih.gov/pubmed/23047498",
        "http://www.ncbi.nlm.nih.gov/pubmed/20465787",
        "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
        "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
        "http://www.ncbi.nlm.nih.gov/pubmed/27995391",
        "http://www.ncbi.nlm.nih.gov/pubmed/12184133",
        "http://www.ncbi.nlm.nih.gov/pubmed/16498275"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
          "text": "Irritable bowel syndrome: diagnosis and pathogenesis.. Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder that considerably reduces the quality of life. It further represents an economic burden on society due to the high con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9189028739929199,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15335408",
          "text": "New pathophysiological mechanisms in irritable bowel syndrome.. Irritable bowel syndrome (IBS) is a functional, multifactorial disease characterized by abdominal pain and erratic bowel habit. Changes in gastrointestinal motor function, enhanced pe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9125818610191345,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
          "text": "Recent developments in the pathophysiology of irritable bowel syndrome.. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder, the pathophysiology of which is not completely known, although it has been shown that genetic/social lea...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.90434730052948,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23047498",
          "text": "Focus on irritable bowel syndrome.. The Irritable bowel syndrome (IBS) is a clinical syndrome characterized by chronic abdominal dis-comfort associated with changes in bowel habits and these symptoms can't be explained by any biochemical or organi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9020017385482788,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20465787",
          "text": "Current insights in to the pathophysiology of Irritable Bowel Syndrome.. Irritable Bowel Syndrome (IBS) represents a functional disorder of gastrointestinal tract without the presence of an anatomic defect, in which abdominal pain is relieved with...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9014289975166321,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
          "text": "Irritable bowel syndrome: emerging paradigm in pathophysiology.. Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, characterized by abdominal pain, bloating, and changes in bowel habits. These symptoms cannot be ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8973579406738281,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
          "text": "Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?. Recent in-depth studies of irritable bowel syndrome (IBS) that assessed multiple physiological endpoints in large patient cohorts confirm evidence o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8925435543060303,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27995391",
          "text": "Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.. Irritable bowel syndrome (IBS) is a prevalent condition affecting 10-20% of adults in most countries; IBS results in significant morbidity and health care costs. IBS is...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8867545127868652,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12184133",
          "text": "Neuropathophysiology of irritable bowel syndrome.. Widespread symptoms associated with the irritable bowel syndrome (IBS) are abnormal defecation and abdominal pain, both of which can be exacerbated by psychogenic stress. Disordered defecation may...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8826124668121338,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16498275",
          "text": "[The pathophysiology of irritable bowel syndrome: inflammation and motor disorder].. Irritable bowel syndrome (IBS) is one of the most common disorders and a heterogeneous condition in view of symptoms and underlying mechanisms. Though underlying ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8787765502929688,
          "rerank_position": 10
        }
      ],
      "id": "67d722e818b1e36f2e000036",
      "type": "summary",
      "body": "Pathophysiology of irritable bowel syndrome (IBS)."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
        "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
        "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
        "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
        "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
        "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
        "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
        "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
        "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
        "http://www.ncbi.nlm.nih.gov/pubmed/39924521"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
          "text": "The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.. The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer. Emerging evidence of Axl upregulation in numerous ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7901603579521179,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
          "text": "Axl as a mediator of cellular growth and survival.. The control of cellular growth and proliferation is key to the maintenance of homeostasis. Survival, proliferation, and arrest are regulated, in part, by Growth Arrest Specific 6 (Gas6) through b...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7750684022903442,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
          "text": "Targeting Axl and Mer kinases in cancer.. Receptor tyrosine kinases (RTK) are cell-surface transmembrane receptors that contain regulated kinase activity within their cytoplasmic domain and play an important role in signal transduction in both nor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7730036973953247,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
          "text": "Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.. Aberrant expression and activation of receptor tyrosine kinases (RTK) is a frequent feature of tumor cells that may underlie tumor aggressiveness. Among RTK, Axl, a membe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7715859413146973,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
          "text": "Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.. IMPORTANCE OF THE FIELD: Axl and/or Mer expression correlates with poor prognosis in several cancers. Until recently, the role of these receptor tyr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7553104162216187,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
          "text": "Giving AXL the axe: targeting AXL in human malignancy.. The receptor tyrosine kinase AXL, activated by a complex interaction between its ligand growth arrest-specific protein 6 and phosphatidylserine, regulates various vital cellular processes, in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7513217926025391,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
          "text": "Axl-dependent signalling: a clinical update.. Axl is a receptor tyrosine kinase that was originally cloned from cancer cells. Axl belongs to the TAM (Tyro3, Axl and Mertk) family of receptor tyrosine kinases. Gas6 (growth-arrest-specific protein 6...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7464035749435425,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
          "text": "Gene of the month: Axl.. The interaction between Axl receptor tyrosine kinase and its main ligand Gas6 has been implicated in the progression of a wide number of malignancies. More recently, overexpression of Axl has emerged as a key molecular det...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409855127334595,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
          "text": "Axl kinase as a key target for oncology: focus on small molecule inhibitors.. Receptor tyrosine kinases (RTK) are transmembrane receptors that regulate signal transduction in cells. As a member of the TAM (Tyro-3, Axl, Mer) RTK subfamily, Axl regu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7264127135276794,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39924521",
          "text": "AXL signaling in cancer: from molecular insights to targeted therapies.. AXL, a member of the TAM receptor family, has emerged as a potential target for advanced-stage human malignancies. It is frequently overexpressed in different cancers and pla...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7240316271781921,
          "rerank_position": 10
        }
      ],
      "id": "67da17c918b1e36f2e000055",
      "type": "summary",
      "body": "What is the role of the receptor tyrosine kinase AXL in malignancy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/36596294",
        "http://www.ncbi.nlm.nih.gov/pubmed/3628047",
        "http://www.ncbi.nlm.nih.gov/pubmed/7247762",
        "http://www.ncbi.nlm.nih.gov/pubmed/3832354",
        "http://www.ncbi.nlm.nih.gov/pubmed/3614146",
        "http://www.ncbi.nlm.nih.gov/pubmed/4176628",
        "http://www.ncbi.nlm.nih.gov/pubmed/6880885",
        "http://www.ncbi.nlm.nih.gov/pubmed/27487372",
        "http://www.ncbi.nlm.nih.gov/pubmed/7313431",
        "http://www.ncbi.nlm.nih.gov/pubmed/10382908"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36596294",
          "text": "Pulmonary function tests for evaluating the severity of Duchenne muscular dystrophy disease.. AIM: In Duchenne muscular dystrophy (DMD), lung disease contributes significantly to morbidity and mortality. This study aimed to assess the usefulness o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6859810948371887,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3628047",
          "text": "[Evaluation of the respiratory function in patients with Duchenne's muscular dystrophy].. The purpose of this investigation was to compare the respiratory function of patients with different clinical stages of Duchenne muscular dystrophy (DMD). Tw...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6813853979110718,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7247762",
          "text": "Loss of strength and functional decline in Duchenne's dystrophy.. Clinical tests of strength and function were performed on 27 ambulatory patients with Duchenne's dystrophy every three months for 2 1/2 years. Linear decline of strength remains a f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6639293432235718,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3832354",
          "text": "[Prognostic evaluation of the cardiopathy in Duchenne's muscular dystrophy].. As it has now been ascertained that there is cardiac damage during the course of Duchenne muscular dystrophy (DMD), the authors have aimed at evaluating the relationship...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6524323225021362,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3614146",
          "text": "[Vital capacity as a prognostic index in Duchenne's muscular dystrophy].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "rerank_score": 0.6496877074241638,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4176628",
          "text": "Correlations between aldolasaemia and motor unit territory in the evaluation of Duchenne's progressive muscular dystrophy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "rerank_score": 0.6462032794952393,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6880885",
          "text": "Alterations of the respiratory function in Duchenne's muscular dystrophy. Observations on 14 cases.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "rerank_score": 0.645915150642395,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27487372",
          "text": "Relationship between muscle strength and motor function in Duchenne muscular dystrophy.. OBJECTIVE: To investigate the relationship between muscle strength and motor function and between these variables and age. METHOD: Muscle strength was measure...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6423789858818054,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7313431",
          "text": "[The pattern of myopathic involvement in Duchenne's muscular dystrophy].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "rerank_score": 0.6346481442451477,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10382908",
          "text": "Correlation of muscle fiber type measurements with clinical and molecular genetic data in Duchenne muscular dystrophy.. Clinical improvement following surgery in patients with Duchenne muscular dystrophy (DMD) may be influenced by the severity of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6335301399230957,
          "rerank_position": 10
        }
      ],
      "id": "66301d1d187cba990d000026",
      "type": "yesno",
      "body": "Are respiratory measurements correlated with disease severity in Duchenne Muscular Dystrophy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
        "http://www.ncbi.nlm.nih.gov/pubmed/23359680",
        "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
        "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
        "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
        "http://www.ncbi.nlm.nih.gov/pubmed/16369839",
        "http://www.ncbi.nlm.nih.gov/pubmed/16450370",
        "http://www.ncbi.nlm.nih.gov/pubmed/20574456",
        "http://www.ncbi.nlm.nih.gov/pubmed/15882803",
        "http://www.ncbi.nlm.nih.gov/pubmed/32207552"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
          "text": "Novel UCHL1 mutations reveal new insights into ubiquitin processing.. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 has been implicated in early-onset progressive neurodegeneration (MIM no. 615491), so far only in one family...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5062264800071716,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23359680",
          "text": "Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.. Ubiquitin C-terminal hydrolase-L1 (UCHL1), a neuron-specific de-ubiquitinating enzyme, is one of the most abundant proteins i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49806320667266846,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
          "text": "Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.. INTRODUCTION: Ubiquitin C-terminal hydrolase L1 (UCHL1) has been associated with a severe, complex autosomal recessive spastic paraple...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4904179871082306,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
          "text": "Digenic FLNA and UCHL1 variants resulting in a complex phenotype.. AIM: X-linked variants in Filamin A (FLNA) are associated with the Ehlers-Danlos-syndrome-variant form of periventricular heterotopia, and autosomal dominant variants in ubiquitin ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46873027086257935,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
          "text": "Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.. PURPOSE: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4362602233886719,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16369839",
          "text": "The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.. An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.435912162065506,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450370",
          "text": "UCHL-1 is not a Parkinson's disease susceptibility gene.. OBJECTIVE: The UCHL-1 gene is widely cited as a susceptibility factor for sporadic Parkinson's disease (PD). The strongest evidence comes from a meta-analysis of small studies that reported...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4247894287109375,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20574456",
          "text": "The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.. De-ubiquitinating enzymes (DUBs) can reverse the modifications catalyzed by ubiquitin ligases and as such are beli...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.404427170753479,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15882803",
          "text": "UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.. To avoid the possible confounding effect of population stratification, we employed a discordant sibling study design and a liberalization of...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4008989930152893,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32207552",
          "text": "Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.. Ubiquitin C-terminal hydrolase 1 (UCHL1) is an enzyme unique for its multiple activity - both ligase and hydrolase. UCHL1 was first identified as an abundant protein found in the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3990268111228943,
          "rerank_position": 10
        }
      ],
      "id": "67d3518718b1e36f2e000008",
      "type": "factoid",
      "body": "Which disease is caused by heterozygous UCHL1 loss-of-function variants?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26791841",
        "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
        "http://www.ncbi.nlm.nih.gov/pubmed/23297721",
        "http://www.ncbi.nlm.nih.gov/pubmed/24051581",
        "http://www.ncbi.nlm.nih.gov/pubmed/25475573",
        "http://www.ncbi.nlm.nih.gov/pubmed/15918011",
        "http://www.ncbi.nlm.nih.gov/pubmed/24876733",
        "http://www.ncbi.nlm.nih.gov/pubmed/18081659",
        "http://www.ncbi.nlm.nih.gov/pubmed/23559319",
        "http://www.ncbi.nlm.nih.gov/pubmed/22242554"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26791841",
          "text": "Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer: Is There an Optimal Succession?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "rerank_score": 0.7274328470230103,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
          "text": "Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.. Colorectal cancer is one of the most common cancers worldwide. In recent years, the survival of patients with metastatic disease has improved d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7134332060813904,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23297721",
          "text": "Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.. Systemic therapy for colorectal cancer liver metastases (CRLM) has undergone significant development in the past 15â€‰years. Therapy regimens co...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7019250988960266,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24051581",
          "text": "Surgery for colorectal liver metastases.. Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6692022085189819,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475573",
          "text": "Surgical management of hepatic metastases of colorectal cancer.. For the 20% of patients with resectable colorectal liver metastases (CRLM), hepatic resection is safe, effective and potentially curative. Factors related to the primary and metastat...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6652308702468872,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15918011",
          "text": "[Standard surgical resection of colorectal liver metastases].. Liver resection for colorectal metastases can be performed with curative intent in about 15-20% of patients. From a surgical point of view, achieving a radical (R0) resection is of par...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6642643213272095,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24876733",
          "text": "Role of surgery in colorectal cancer liver metastases.. Colorectal carcinoma (CRC) is the third most common cancer, and approximately 35%-55% of patients with CRC will develop hepatic metastases during the course of their disease. Surgical resecti...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.654839277267456,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081659",
          "text": "Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment.. BACKGROUND: Liver metastases of colorectal cancer occur frequently, but only 10-20% are eligible for liver surgery. Recent new developments ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6547841429710388,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23559319",
          "text": "[Management of synchronous colorectal liver metastases].. At time of diagnosis, 10 to 25% of patients with colorectal cancer present synchronous liver metastases. The treatment of such patients remains controversial without any evidence based orga...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6500738859176636,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22242554",
          "text": "Simultaneous surgery for primary colorectal cancer and metastatic lesions?. Approximately 20-25% of patients with colorectal cancer present with liver metastases at the time of diagnosis. Traditionally, resection of the primary tumor has been advo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.648612380027771,
          "rerank_position": 10
        }
      ],
      "id": "662154f0b9f8b89d7e000009",
      "type": "factoid",
      "body": "What is the most appropriate systemic treatment for conversion therapy in colorectal cancer with potentially resectable liver metastasis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
        "http://www.ncbi.nlm.nih.gov/pubmed/16643767",
        "http://www.ncbi.nlm.nih.gov/pubmed/9097734",
        "http://www.ncbi.nlm.nih.gov/pubmed/38977082",
        "http://www.ncbi.nlm.nih.gov/pubmed/9891890",
        "http://www.ncbi.nlm.nih.gov/pubmed/34509436",
        "http://www.ncbi.nlm.nih.gov/pubmed/24105633",
        "http://www.ncbi.nlm.nih.gov/pubmed/15804763",
        "http://www.ncbi.nlm.nih.gov/pubmed/32950958",
        "http://www.ncbi.nlm.nih.gov/pubmed/11284745"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
          "text": "Interplay between aging and other factors of the pathogenesis of age-related macular degeneration.. Age-related macular degeneration (AMD) is a complex eye disease with the retina as the target tissue and aging as per definition the most serious r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6244450211524963,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16643767",
          "text": "[Aging and age-related macular degeneration].. Aging is a common feature of biological changes in the eye, especially in the retina. It is recognized that the pathogenesis of age-related macular degeneration (AMD) involves changes of RPE-Bruch mem...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6162394285202026,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097734",
          "text": "Pathogenesis of AMD.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 20,
          "rerank_score": 0.6149963140487671,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38977082",
          "text": "Aging of the eye: Lessons from cataracts and age-related macular degeneration.. Aging is the greatest risk factor for chronic human diseases, including many eye diseases. Geroscience aims to understand the effects of the aging process on these dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6119073629379272,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9891890",
          "text": "Age-related macular degeneration: review of pathogenesis.. Age-related macular degeneration is a condition (a) characterized by accumulation of membranous debris on both sides of the retinal pigment epithelium (RPE) basement membrane. Clinical man...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5937421321868896,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34509436",
          "text": "An Update on the Hemodynamic Model of Age-Related Macular Degeneration.. PURPOSE: To provide an update on the hemodynamic model of age-related macular degeneration (AMD). DESIGN: Evidence-based perspective. METHODS: Review of the literature and ex...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5756709575653076,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24105633",
          "text": "Mechanisms of age-related macular degeneration and therapeutic opportunities.. As the age of the population increases in many nations, age-related degenerative diseases pose significant socioeconomic challenges. One of the key degenerative disease...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5721518993377686,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15804763",
          "text": "Immunological factors in the pathogenesis and treatment of age-related macular degeneration.. Recent findings indicate that immunological factors are involved not only in the pathogenesis of age-related macular degeneration (AMD), but also in its ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5578900575637817,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32950958",
          "text": "Role of retinal pigment epithelium in age-related macular disease: a systematic review.. Age-related macular disease (AMD) is a major cause of blindness and there is little treatment currently available by which the progress of the basic disorder ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5538859367370605,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11284745",
          "text": "Ocular perfusion and age-related macular degeneration.. PURPOSE: To review the role of ocular perfusion in the pathophysiology of age-related macular degeneration (AMD), the leading cause of irreversible blindness in the industrialized world. METH...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5538531541824341,
          "rerank_position": 10
        }
      ],
      "id": "67c847f581b1027333000003",
      "type": "yesno",
      "body": "Is age an underlying factor in the eye disease AMD?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
        "http://www.ncbi.nlm.nih.gov/pubmed/24983096",
        "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
        "http://www.ncbi.nlm.nih.gov/pubmed/28429288",
        "http://www.ncbi.nlm.nih.gov/pubmed/30875715",
        "http://www.ncbi.nlm.nih.gov/pubmed/30311585",
        "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
        "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
        "http://www.ncbi.nlm.nih.gov/pubmed/27509655",
        "http://www.ncbi.nlm.nih.gov/pubmed/26996139"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
          "text": "Zika Virus.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 11,
          "rerank_score": 0.8752039670944214,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24983096",
          "text": "Zika virus.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 11,
          "rerank_score": 0.8752039670944214,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
          "text": "[Zika virus].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 13,
          "rerank_score": 0.8593331575393677,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28429288",
          "text": "Zika virus, a novel mosquito-borne congenital virus infection.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 62,
          "rerank_score": 0.8049920201301575,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30875715",
          "text": "New Advances on Zika Virus Research.. Zika virus (ZIKV) is an emerging mosquito-borne member of the Flaviviridae family that has historically been known to cause sporadic outbreaks, associated with a mild febrile illness, in Africa and Southeast A...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7579649686813354,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30311585",
          "text": "Zika Virus: A Critical Analysis and Pharmaceutical Perspectives.. Zika virusÂ belongs to family of virusesÂ 'Flaviviridae' and spreads mostlyÂ by daytime-activeÂ AedesÂ mosquitoes. The resulting infection is known asÂ Zika fever. It is usually asymptoma...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7415019273757935,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
          "text": "Zika Virus Mosquito Vectors: Competence, Biology, and Vector Control.. Zika virus (ZIKV) (Flaviviridae, Flavivirus) has become one of the most medically important mosquito-borne viruses because of its ability to cause microcephaly in utero and Gui...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409052848815918,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
          "text": "The Zika outbreak of the 21st century.. The Zika virus outbreak has captivated the attention of the global audience and information has spread rapidly and wildly through the internet and other media channels. This virus was first identified in 194...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7354503870010376,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27509655",
          "text": "[ZIKA--VIRUS INFECTION].. This review summarizes the knowledge of the scientific community for Zika-virus infection. It became popular because of severe congenital damage causes of CNS in newborns whose mothers are infected during pregnancy, as we...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7298095226287842,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26996139",
          "text": "Zika virus: History, emergence, biology, and prospects for control.. Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cau...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7234710454940796,
          "rerank_position": 10
        }
      ],
      "id": "67d7fe2618b1e36f2e000044",
      "type": "factoid",
      "body": "Vector of zika virus."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30946477",
        "http://www.ncbi.nlm.nih.gov/pubmed/29383547",
        "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
        "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
        "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
        "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
        "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
        "http://www.ncbi.nlm.nih.gov/pubmed/27617697",
        "http://www.ncbi.nlm.nih.gov/pubmed/29849920",
        "http://www.ncbi.nlm.nih.gov/pubmed/20941832"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30946477",
          "text": "The landscape of the mesenchymal signature in brain tumours.. The complexity of glioblastoma multiforme, the most common and lethal variant of gliomas, is reflected by cellular and molecular heterogeneity at both the inter- and intra-tumoural leve...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.714134931564331,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29383547",
          "text": "New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.. Neural stem cells (NSCs) undergo self-renewal and generate neurons and glial cells under the influence of specific signals from surroundin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6741671562194824,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
          "text": "Mesenchymal differentiation of glioblastoma stem cells.. Glioblastoma multiforme is a severe form of cancer most likely arising from the transformation of stem or progenitor cells resident in the brain. Although the tumorigenic population in gliob...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6432060599327087,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
          "text": "Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.. Glioblastoma multiforme (GBM) is paradigmatic for the investigation of cancer stem cells (CSC) in solid tumors. Growing e...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.638648271560669,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29387965",
          "text": "Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.. First described in the 1800s, glioblastoma multiforme (GBM), a class IV neoplasm with astrocytic differentiation, as per the revised 2016 World Health Organiz...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6335470080375671,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
          "text": "Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.. Glioblastoma, also known as glioblastoma multiforme (GBM), is one of the most lethal human cancers, however, the molecular mechanisms driving GBM remain lar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6290135383605957,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
          "text": "Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.. Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. In addition to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6161240935325623,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27617697",
          "text": "The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer due to its highly invasive nature that impe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6126717925071716,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29849920",
          "text": "Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme.. Glioblastoma multiforme (GBM) (grade IV astrocytoma) has been assumed to be the most fatal type of glioma with low survival and high recurrence rates, even after prompt s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.606099545955658,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941832",
          "text": "Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.. PURPOSE: Brain tumors are the leading cause of cancer mortality in children and remain incurable despite advances in surgery and adjuvant therapies. T...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6055527925491333,
          "rerank_position": 10
        }
      ],
      "id": "67d7503018b1e36f2e00003e",
      "type": "list",
      "body": "What are the main transcription factors driving the mesenchymal-like (MES-like) state of glioblastoma multiforme?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34537679",
        "http://www.ncbi.nlm.nih.gov/pubmed/37565404",
        "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
        "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
        "http://www.ncbi.nlm.nih.gov/pubmed/38193360",
        "http://www.ncbi.nlm.nih.gov/pubmed/32151945",
        "http://www.ncbi.nlm.nih.gov/pubmed/38266156",
        "http://www.ncbi.nlm.nih.gov/pubmed/37165958",
        "http://www.ncbi.nlm.nih.gov/pubmed/38916676",
        "http://www.ncbi.nlm.nih.gov/pubmed/32548277"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34537679",
          "text": "Investigating RFC1 expansions in sporadic amyotrophic lateral sclerosis.. A homozygous AAGGG repeat expansion within the RFC1 gene was recently described as a common cause of CANVAS syndrome. We examined 1069 sporadic ALS patients for the presence...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6204235553741455,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37565404",
          "text": "Non-GAA Repeat Expansions in FGF14 Are Likely Not Pathogenic-Reply to: \"Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and Unaffected Members of a Chilean Family\".",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "rerank_score": 0.5748588442802429,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
          "text": "Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations.. A biallelic pentanucleotide expansion in the RFC1 gene has been reported to be a common cause of late-onset ataxia. In ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5679148435592651,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
          "text": "Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies.. Biallelic expansions of the AAGGG repeat in the replication factor C subunit 1 (RFC1) have recently been described to be responsible for cerebell...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5640353560447693,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38193360",
          "text": "Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.. RFC1 disease, caused by biallelic repeat expansion in RFC1, is clinically heterogeneous in terms of age of onset, disease progression and phenotype. We inv...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5570947527885437,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32151945",
          "text": "No biallelic intronic AAGGG repeat expansion in RFC1 was found in patients with late-onset ataxia and MSA.. We screened the RFC1 intronic AAGGG repeat expansions in late-onset ataxia cases, MSA patients and controls. The data suggested that no bia...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5524985790252686,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38266156",
          "text": "Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.. An expansion of AAGGG pentanucleotide repeats in the replication factor C subunit 1 (RFC1) gene is...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5488371849060059,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37165958",
          "text": "Detection of the ACAGG Repeat Motif in RFC1 in Two Dutch Ataxia Families.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 73,
          "rerank_score": 0.5464977622032166,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38916676",
          "text": "Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease.. Biallelic pathogenic repeat expansions in RFC1 were recently identified as molecular ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5416063070297241,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32548277",
          "text": "Intronic pentanucleotide expansion in the replication factor 1 gene (RFC1) is a major cause of adult-onset ataxia.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 114,
          "rerank_score": 0.5354127883911133,
          "rerank_position": 10
        }
      ],
      "id": "67d34fb318b1e36f2e000007",
      "type": "factoid",
      "body": "Which role does AAAGG have in RFC1 repeat expansions?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
        "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
        "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
        "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
        "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
        "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
        "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
        "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
        "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
        "http://www.ncbi.nlm.nih.gov/pubmed/30796810"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
          "text": "Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.. The identification of several genetic mutations in colorectal cancer (CRC) has allowed a better comprehension of the prognosis and response to diffe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7681597471237183,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
          "text": "Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.. The colorectal cancer (CRC) Subtyping Consortium has unified six independent molecular classification systems, based on gene expression data, into a single consens...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7628440856933594,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
          "text": "Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.. BACKGROUND: The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture tumor heterogeneity at the gene-expression level. C...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7618083953857422,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
          "text": "Investigation of colorectal cancer in accordance with consensus molecular subtype classification.. The classification of colorectal cancer (CRC) plays a pivotal role in predicting a patient's prognosis and determining treatment strategies. The con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7545981407165527,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
          "text": "The consensus molecular subtypes of colorectal cancer.. Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene expression-based CRC classifications ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.72785484790802,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
          "text": "Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.. Cancer is a heterogeneous disease and many cancer types do not represent a single entity, but are composed of biologically and clinically diverse subtypes. The su...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7274397611618042,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
          "text": "Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management.. Colorectal cancer (CRC) is the second cause of cancer-related deaths in both sexes globally and presents different clinical outcomes that are described by a r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7267495393753052,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
          "text": "Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.. Background Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.72062087059021,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
          "text": "Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.. BACKGROUND: Colorectal cancer is a complex disease with high mortality rates. Over time, the treatment of metastatic co...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7198373079299927,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30796810",
          "text": "Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.. The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7167458534240723,
          "rerank_position": 10
        }
      ],
      "id": "662fc277187cba990d000013",
      "type": "yesno",
      "body": "Does the consensus molecular subtype (CMS) classification for colorectal cancer any use in routine clinical practice?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19736396",
        "http://www.ncbi.nlm.nih.gov/pubmed/27104824",
        "http://www.ncbi.nlm.nih.gov/pubmed/29427800",
        "http://www.ncbi.nlm.nih.gov/pubmed/22591620",
        "http://www.ncbi.nlm.nih.gov/pubmed/19685828",
        "http://www.ncbi.nlm.nih.gov/pubmed/26228363",
        "http://www.ncbi.nlm.nih.gov/pubmed/36870204",
        "http://www.ncbi.nlm.nih.gov/pubmed/30155958",
        "http://www.ncbi.nlm.nih.gov/pubmed/27003987",
        "http://www.ncbi.nlm.nih.gov/pubmed/16701503"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19736396",
          "text": "Established and potential risk factors for Clostridum difficile infection.. Clostridium difficile is the aetiological agent for almost all cases of pseudo membranous colitis and 15-25% of antibiotic associated diarrhoea. In recent years, C. diffic...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6682866811752319,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27104824",
          "text": "Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile.. Besides genetics and environmental factors, intestinal microbiota seem to play a major role in the pathogenesis of inflammatory bowel diseases. For m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5718557238578796,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29427800",
          "text": "New insights into transmission of Clostridium difficile infection-narrative review.. BACKGROUND: Traditionally, Clostridium difficile has been considered a typical healthcare-associated pathogen-that is, one transmitted within healthcare facilitie...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5492583513259888,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22591620",
          "text": "Statins and Clostridum difficile: a clinically relevant interaction?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 68,
          "rerank_score": 0.5362600088119507,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19685828",
          "text": "[Clostridum difficile associated disease in Latin America].. Clostridium difficile associated disease (CDAD) has shown a sustained increase worldwide over the last ten years. However, there are few studies on this topic in Latin America. We conduc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5262737274169922,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26228363",
          "text": "The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.. There is growing recognition of the impact of Clostridum difficile infection (CDI) on patients with inflammatory bowel dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5107979774475098,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36870204",
          "text": "Clostridial diarrheas in piglets: A review.. Clostridium perfringens type C and Clostridioides difficile are the main enteric clostridial pathogens of swine and are both responsible for neonatal diarrhea in this species. The role of Clostridum per...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5089595317840576,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30155958",
          "text": "Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection.. We report the case of a 3-year-old male who developed recurrent Clostridium difficile infection after receiving an orthotopic heart tr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49767541885375977,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27003987",
          "text": "Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.. Antibiotic-associated diarrhea (AAD) and Clostridium difficile infections (CDI) have been well studied for adult cases, but not as well in the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.47757428884506226,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16701503",
          "text": "The development of Clostridium difficile genetic systems.. Clostridum difficile is a major cause of healthcare-associated disease in the western world, and is particularly prominent in the elderly. Its incidence is rising concomitant with increasi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.43393170833587646,
          "rerank_position": 10
        }
      ],
      "id": "67cddce881b102733300001c",
      "type": "list",
      "body": "Please list major complications of Clostridum Difficile infection."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22375502",
        "http://www.ncbi.nlm.nih.gov/pubmed/16817431",
        "http://www.ncbi.nlm.nih.gov/pubmed/14704263",
        "http://www.ncbi.nlm.nih.gov/pubmed/15693578",
        "http://www.ncbi.nlm.nih.gov/pubmed/17893687",
        "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
        "http://www.ncbi.nlm.nih.gov/pubmed/17454455",
        "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
        "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
        "http://www.ncbi.nlm.nih.gov/pubmed/26137726"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22375502",
          "text": "[Polycystic ovarian syndrome].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 30,
          "rerank_score": 0.9302667379379272,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16817431",
          "text": "[Polycystic ovarian syndrome].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 30,
          "rerank_score": 0.9302667379379272,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14704263",
          "text": "Polycystic ovary syndrome.. Women with polycystic ovarian syndrome have chronic anovulation and androgen excess not attributable to another cause. This condition occurs in approximately 4% of women. The fundamental pathophysiologic defect is unkno...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8867834806442261,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15693578",
          "text": "Diagnosis and treatment of polycystic ovarian syndrome.. Polycystic ovarian syndrome is a hormonal disturbance that results in a collection of symptoms and has wide-ranging health implications. There is evidence that it may run in families, and it...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8842114806175232,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17893687",
          "text": "The reproductive phenotype in polycystic ovary syndrome.. The symptoms of women with polycystic ovary syndrome (PCOS) include hirsutism and irregular menstrual bleeding due to ovarian androgen excess and chronic anovulation. Typically, these featu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8778787851333618,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
          "text": "Diagnosis of polycystic ovary syndrome.. The clinical features of polycystic ovary syndrome (PCOS) include hirsutism and irregular menses, which are the results of ovarian hyperandrogenism and chronic, unopposed estrogen secretion. The discovery t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8490593433380127,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17454455",
          "text": "Therapeutic options in the polycystic ovary syndrome.. The polycystic ovary syndrome is the most common endocrine disorder affecting women. It is a heterogeneous familial condition of uncertain aetiology. The diagnosis is made by the detection of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8409844636917114,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
          "text": "[Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].. Polycystic ovarian syndrome represents the most common endocrine disease of women of reproductive age. Symptoms include metabolic, gynecologic and cosmetic feature...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.833497166633606,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
          "text": "[Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].. The polycystic ovary syndrome (PCOS), then called the Stein-Leventhal syndrome, was first described in 1935. Originally, diagnosis ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8299176096916199,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26137726",
          "text": "Polycystic Ovarian Syndrome: A Primer.. Polycystic ovary syndrome (PCOS) affects 8-10 percent of reproductive-aged females, making it the most common state of endocrine dysfunction in women. Patients with PCOS are often treated for the signs and s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8291078805923462,
          "rerank_position": 10
        }
      ],
      "id": "67d43cd218b1e36f2e000011",
      "type": "list",
      "body": "Symptoms of polycystic ovarian syndrome."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/38052500",
        "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
        "http://www.ncbi.nlm.nih.gov/pubmed/39042298",
        "http://www.ncbi.nlm.nih.gov/pubmed/20142420",
        "http://www.ncbi.nlm.nih.gov/pubmed/27128881",
        "http://www.ncbi.nlm.nih.gov/pubmed/24982138",
        "http://www.ncbi.nlm.nih.gov/pubmed/30347186",
        "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
        "http://www.ncbi.nlm.nih.gov/pubmed/37286422",
        "http://www.ncbi.nlm.nih.gov/pubmed/21372517"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38052500",
          "text": "Features, Fates, and Functions of Oligodendrocyte Precursor Cells.. Oligodendrocyte precursor cells (OPCs) are a central nervous system resident population of glia with a distinct molecular identity and an ever-increasing list of functions. OPCs g...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7497904300689697,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
          "text": "Oligodendrocyte progenitor cell fate and function in development and disease.. Differentiation of oligodendrocyte progenitor cells (OPCs) into myelination-capable mature oligodendrocytes is essential for proper function of the central nervous syst...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7102332711219788,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39042298",
          "text": "A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System.. Oligodendrocyte precursor cells (OPCs) are a heterogeneous multipotent population in the central nervous system (CNS) that appear during embryogenesis and persis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7095582485198975,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20142420",
          "text": "Tapping into the glial reservoir: cells committed to remaining uncommitted.. The development and maturation of the oligodendrocyte requires a series of highly orchestrated events that coordinate the proliferation and differentiation of the oligode...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7010146379470825,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27128881",
          "text": "The environment rules: spatiotemporal regulation of oligodendrocyte differentiation.. During development oligodendrocyte precursor cells (OPCs) rapidly proliferate and migrate throughout the central nervous system. The mobilization of OPCs is foll...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6990154981613159,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24982138",
          "text": "Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.. Human oligodendrocyte progenitor cell (OPC) specification and differentiation occurs slowly and limits the potential for cell-based treatment of demyelin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6981295347213745,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30347186",
          "text": "Sequential specification of oligodendrocyte lineage cells by distinct levels of Hedgehog and Notch signaling.. During development of the central nervous system oligodendrocyte precursor cells (OPCs) give rise to both myelinating oligodendrocytes a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6952683925628662,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
          "text": "Molecular Control of Oligodendrocyte Development.. Myelin is a multilayer lipid membrane structure that wraps and insulates axons, allowing for the efficient propagation of action potentials. During developmental myelination of the central nervous...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6899049282073975,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37286422",
          "text": "Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling.. Oligodendrocyte precursor cells (OPCs) are non-neuronal brain cells that give rise to oligodendrocytes, glia that myelinate the axons of neurons in th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.686684250831604,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21372517",
          "text": "Differential gene expression in oligodendrocyte progenitor cells, oligodendrocytes and type II astrocytes.. Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or func...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6836134195327759,
          "rerank_position": 10
        }
      ],
      "id": "67d9f6a418b1e36f2e000051",
      "type": "list",
      "body": "What are the lineage transcription factors of oligodendrocyte progenitor cells (OPCs)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
        "http://www.ncbi.nlm.nih.gov/pubmed/17686445",
        "http://www.ncbi.nlm.nih.gov/pubmed/21376511",
        "http://www.ncbi.nlm.nih.gov/pubmed/20558582",
        "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
        "http://www.ncbi.nlm.nih.gov/pubmed/37428988",
        "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
        "http://www.ncbi.nlm.nih.gov/pubmed/25527907",
        "http://www.ncbi.nlm.nih.gov/pubmed/31539267",
        "http://www.ncbi.nlm.nih.gov/pubmed/28518058"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
          "text": "Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.. Accurate survival prediction for Non-Small Cell Lung Cancer (NSCLC) patients remains a signific...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.62274169921875,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17686445",
          "text": "How could pharmacogenomics help improve patient survival?. Increasing knowledge regarding multiple genetic disturbances found in human lung cancers, particularly non-small cell lung cancer (NSCLC), have enabled predictive markers to be used in spe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.506067156791687,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21376511",
          "text": "[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].. Targeted therapies booming and new efficacious cytotoxics emergence in non-...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5033731460571289,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20558582",
          "text": "How accurate are physicians in the prediction of patient survival in advanced lung cancer?. BACKGROUND: Because most cases of non-small cell lung cancer (NSCLC) are diagnosed at an advanced stage with a poor prognosis, patient inclusion in clinica...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.49769455194473267,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
          "text": "The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.. BACKGROUND: Systemic therapy prolongs overall survival (OS) in advanced non-small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.48131459951400757,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37428988",
          "text": "Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.. PURPOSE: Stratifying patients with cancer according to risk of relapse can personalize their care. In this work, we provide an answer to the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4700682461261749,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
          "text": "Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.. The aim of this article is to summarise the published data on prognostic and predictive biomarkers for early-stage non-small cell ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4637758135795593,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25527907",
          "text": "Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.. BACKGROUND: Response Evaluation Criteria in Solid Tumors (RECIST) are widely used to assess the effect of chemotherapy in patients with cancer. We hypothesised ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.45001131296157837,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31539267",
          "text": "Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.. PURPOSE: The prediction of clinical outcomes for patients with cancer is central to precision medicine and the desig...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.44469112157821655,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28518058",
          "text": "Prediction of NSCLC recurrence from microarray data with GEP.. Lung cancer is one of the deadliest diseases in the world. Non-small cell lung cancer (NSCLC) is the most common and dangerous type of lung cancer. Despite the fact that NSCLC is preve...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.43757277727127075,
          "rerank_position": 10
        }
      ],
      "id": "67d7531018b1e36f2e000041",
      "type": "list",
      "body": "Data from which clinical trials have been used to demonstrate use of knowledge graphs for NSCLC survival prediction?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20233459",
        "http://www.ncbi.nlm.nih.gov/pubmed/24667094",
        "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
        "http://www.ncbi.nlm.nih.gov/pubmed/31777463",
        "http://www.ncbi.nlm.nih.gov/pubmed/3035696",
        "http://www.ncbi.nlm.nih.gov/pubmed/27339646",
        "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
        "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
        "http://www.ncbi.nlm.nih.gov/pubmed/1847273",
        "http://www.ncbi.nlm.nih.gov/pubmed/8813770"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20233459",
          "text": "In the beginning there was colectomy: current surgical options in familial adenomatous polyposis.. Multiple colonic polyps, almost guaranteed colorectal cancer by the age of forty-five and an increased risk of non-colonic cancers characterise the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7543259859085083,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24667094",
          "text": "[Surgical options for familial adenomatous polyposis depending on genetic factors].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.7514615058898926,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
          "text": "Surgical options for familial adenomatous polyposis.. Familial adenomatous polyposis (FAP) is a genetic disorder transmitted in an autosomal dominant pattern. One-half of members of an affected family will carry the gene, and all carriers will suc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7481940984725952,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31777463",
          "text": "Adenomatous Polyposis Syndromes: Diagnosis and Management.. Familial adenomatous polyposis (FAP) syndromes make up fewer than 1% of patients diagnosed with colorectal cancer each year. Patients with familial polyposis syndromes including FAP, atte...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7481842041015625,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3035696",
          "text": "Surgical alternatives in the treatment of polyposis coli.. The history of familial polyposis coli and its various surgical treatment alternatives are presented. Each form of treatment has advantages and disadvantages. The menu of alternatives allo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7408342957496643,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339646",
          "text": "[Surgical aspects of indications and techniques for adenomatous polyposis variants].. Due to the advances in molecular genetic diagnostics of adenomatous polyposis variants, identification of patients with a genetic predisposition and their at ris...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.727037787437439,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
          "text": "Operations for familial adenomatous polyposis.. The purpose of this article is to discuss the advantages and disadvantages of surgical procedures designed to eliminate the risk of colorectal cancer, the surgical treatment of extracolonic polyps, a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7221982479095459,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
          "text": "Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations.. Familial adenomatous polyposis (FAP) is an autosomal dominant inherited syndrome characterized by multiple adenomatous polyps (predisposing to colorectal ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7214018106460571,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1847273",
          "text": "Choice of operation in familial adenomatous polyposis.. There are 3 surgical options for patients who have familial adenomatous polyposis. None of them guarantees a 100% cure of the disease, although they all minimize or eliminate the risk of colo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7191839218139648,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8813770",
          "text": "Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis.. The surgical options for treating the large bowel component of familial adenomatous polyposis are total proctocolectomy, colectomy with ileorectal ana...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7109370827674866,
          "rerank_position": 10
        }
      ],
      "id": "660999a0fdcbea915f00001a",
      "type": "list",
      "body": "What are the colorectal surgical options for patients with Familial Polyposis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
        "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
        "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
        "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
        "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
        "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
        "http://www.ncbi.nlm.nih.gov/pubmed/34458603",
        "http://www.ncbi.nlm.nih.gov/pubmed/36153662",
        "http://www.ncbi.nlm.nih.gov/pubmed/34013567",
        "http://www.ncbi.nlm.nih.gov/pubmed/22059643"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?. Several years ago, dozens of cases were described in patients with symptoms very similar to mucopolysaccharidosis (MPS). This ne...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8091616630554199,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
          "text": "Mucopolysaccharidosis-Plus Syndrome.. Previously, we reported a novel disease of impaired glycosaminoglycans (GAGs) metabolism without deficiency of known lysosomal enzymes-mucopolysaccharidosis-plus syndrome (MPSPS). MPSPS, whose pathophysiology ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7941836714744568,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
          "text": "Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.. Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventio...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7359828352928162,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel VPS33A Variant with Comparison with Other Described Patients.. Eleven patients from Yakutia with a new lysosomal disease assumed then as mucopolysaccharidosis-plus syndro...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6746304035186768,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
          "text": "Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS).. Mucopolysaccharidosis-plus syndrome (MPSPS) is an autosomal-recessive disorder caused by c.1492C>T (p.R498W) in the VPS33A gene. MPSPS is a severe disorder that causes a short lif...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6057068109512329,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
          "text": "Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.. Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder cau...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5878420472145081,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34458603",
          "text": "Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation.. Mucopolysaccharidoses (MPSs) are a heterogeneous group of diseases that have in common the accumul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5745351314544678,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36153662",
          "text": "Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A.. A rare and fatal disease resembling mucopolysaccharidosis in infants, is caused by impaired intracellular endocytic trafficking due to deficiency of core compone...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5436272025108337,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34013567",
          "text": "Homozygous missense VPS16 variant is associated with a novel disease, resembling mucopolysaccharidosis-plus syndrome in two siblings.. Disorders of intracellular trafficking are a group of inherited disorders, which often display multisystem pheno...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5251376628875732,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22059643",
          "text": "Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.. UNLABELLED: Mucopolysaccharidosis type II (MPS II) is a rare, life-limiting, X-linked recessive disease characterised by...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5163270831108093,
          "rerank_position": 10
        }
      ],
      "id": "67c7708481b1027333000002",
      "type": "yesno",
      "body": "Is mucopolysaccharidosis-plus syndrome (MPSPS) a X-linked disease?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
        "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
        "http://www.ncbi.nlm.nih.gov/pubmed/964850",
        "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
        "http://www.ncbi.nlm.nih.gov/pubmed/1297591",
        "http://www.ncbi.nlm.nih.gov/pubmed/2056934",
        "http://www.ncbi.nlm.nih.gov/pubmed/9254565",
        "http://www.ncbi.nlm.nih.gov/pubmed/29205981",
        "http://www.ncbi.nlm.nih.gov/pubmed/2068495",
        "http://www.ncbi.nlm.nih.gov/pubmed/3406636"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
          "text": "[Indications for cesarean section].. Following introductory remarks on rates of cesarean section, the relative and absolute indications for the procedure are reviewed. The rise in the rate of cesarean sections is due to widening of the relative in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8396786451339722,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
          "text": "[Indication for Caesarean section delivery].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 44,
          "rerank_score": 0.8283350467681885,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/964850",
          "text": "[Indications for vital and preventive cesarean section].. The indications for Caesarean section have not only increased but also changed. A spectrum of indications is described which comprises emergency and preventive indications. The postpartal s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7633949518203735,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
          "text": "[Caesarean section--indication or choice?].. Currently, caesarean section is the most commonly indicated procedure. The proportion of caesarean deliveries continues to rise. And the spectrum of surgical indications has dramatically broadened. This...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7418526411056519,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1297591",
          "text": "[Cesarean section: descriptive epidemiology. Increase in frequency of indications for cesarean section].. The use of caesarean section is constantly increasing in all countries of the western world. This article considers various aspects of the ph...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7299851775169373,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2056934",
          "text": "Cesarean section: science or ritual surgery?. Cesarean section has proven to be a powerful weapon in saving fetal and maternal life when scientific criteria are used in a variety of emergency conditions. However, because of the high incidence of f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7238001823425293,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9254565",
          "text": "[The relationship between the outcome of a free vaginal birth and the indications for a prior cesarean section].. The author sets up the task to analyse the correlation between the results of vaginal delivery and the indications for a previous Cae...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7216272354125977,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29205981",
          "text": "Pregnancy and delivery after a cesarean section.. One out of seven of all parturients and one out of five primigravid women deliver by caesarean section. Of four women having undergone caesarean section, three will give birth vaginally, provided t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7171386480331421,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2068495",
          "text": "[How to reduce the number of cesareans in teaching hospitals?].. The authors analyze their indications for cesareans for the year 1989, stressing the possibility of doing fewer. They carry out a critical analysis of the various indications by comp...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7048856019973755,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3406636",
          "text": "[Vaginal cesarean sections].. Vaginal caesarean section, or Durhssen's procedure, is seldom performed in France. Although its indications are exceptional, it enables to rapidly deliver a small fetus minimal maternal trauma without compromising the...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6989392042160034,
          "rerank_position": 10
        }
      ],
      "id": "67d7201b18b1e36f2e00002c",
      "type": "list",
      "body": "Indications of cesarean section."
    }
  ]
}